Previous Close | 0.0100 |
Open | 0.0100 |
Bid | 0.0050 x 0 |
Ask | 0.0100 x 0 |
Day's Range | 0.0100 - 0.0100 |
52 Week Range | 0.0050 - 0.0250 |
Volume | |
Avg. Volume | 685,012 |
Market Cap | 3.357M |
Beta (5Y Monthly) | 1.69 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Vancouver, British Columbia--(Newsfile Corp. - March 22, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce the appointment of Dr. Herbert Fritsche to the Company's Advisory Board as its Chief Scientific Advisor. Dr. Fritsche is a world-renowned Clinical Chemist and former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas MD Anderson Cancer Center for 41 years.Dr. Fritsche ..
Vancouver, British Columbia--(Newsfile Corp. - March 21, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") announces that the Company has now added additional exclusive global licenses for the countries of Israel, and the European Union (with extension to Morocco) from Apollon Formularies, plc. These new exclusive licenses are in addition to the previously announced exclusive licenses for the United States, Canada, and Mexico with the ...
Vancouver, British Columbia--(Newsfile Corp. - March 20, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") announces that Stephen D. Barnhill Jr. has been appointed interim President & CEO effective immediately. Curt Huber, former President & CEO will remain as a Director of the Company and will oversee GHG's continuing industrial hemp related business segments.Mr. Barnhill is currently the Chief Operating Officer (COO) of Apollon Formularies, ...